VEGF antagonist formulations suitable for intravitreal administration | Patent Application Number 16739559

16739559
Not Appealed
Patent NumberUS 11084865 B2
Publication NumberUS 20200131246 A1
Filled DateJan 10, 2020
Priority DateJun 16, 2006
Inventor/ApplicantsEric FURFINE
Daniel DIX
Kelly FRYE
Kenneth GRAHAM
Kenneth Graham
Eric Furfine
Daniel Dix
Kelly Frye
ExaminesLOCKARD, JON MCCLELLAND
Art Unit1647
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.